Targeting leukotriene B₄ in inflammation

Author： Di Gennaro Antonio Haeggström Jesper Z

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.18, Iss.1, 2014-01, pp. : 79-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Application of leukotriene B4 and reflectance confocal microscopy as a noninvasive in vivo model to study the dynamics of skin inflammation

SKIN RESEARCH AND TECHNOLOGY, Vol. 21, Iss. 2, 2015-05 ,pp. : 232-240

John Wiley & Sons Inc

Access to resources Recommend Favorite

Leukotriene C4 Synthase: Upcoming Drug Target For Inflammation

Current Drug Targets, Vol. 13, Iss. 8, 2012-07 ,pp. : 1114-1125

Bentham Science Publishers

Access to resources Recommend Favorite

Distribution of leukotriene B4 receptors in human hematopoietic cells

By Dasari V.R. Jin J. Kunapuli S.P.

Immunopharmacology, Vol. 48, Iss. 2, 2000-07 ,pp. : 157-163

Elsevier

Access to resources Recommend Favorite

Combination of a cyclooxygenase-2 inhibitor with a leukotriene B₄ receptor antagonist

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 7, 1997-07 ,pp. : 765-766

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B 4 biosynthesis in human polymorphonuclear leukocytes

By Denis D. Riendeau D.

European Journal of Pharmacology, Vol. 367, Iss. 2, 1999-02 ,pp. : 343-350

Elsevier

Access to resources Recommend Favorite